文献速递血栓与止血

血流条件下凝血数学模型确定因子V为血友病A凝血酶生成修饰因子

A mathematical model of coagulation under flow identifies factor V as a modifier of thrombin generation in hemophilia A.
PubMed 文献 · J Thromb Haemost · 2019-11-01

本研究利用经血流介导凝血数学模型进行全局敏感性分析,筛选血友病A中增强凝血酶生成的潜在修饰因子,并在校准自动血栓成像和胶原-组织因子表面流动实验中验证。模拟与实验均显示低正常水平因子V(50%)是最强修饰因子,与高正常水平凝血酶原(150%)联合时效果增强。部分抑制因子V(60%活性)可提升凝血酶生成和纤维蛋白沉积。

要点

  • 低正常水平因子V(50%)可增强血友病A凝血酶生成。
  • 高正常水平凝血酶原(150%)可放大因子V降低的效应。
  • 部分抑制因子V(60%活性)在流动实验中增加纤维蛋白沉积。

核心结论

  • 低正常水平因子V可增强血友病A中的凝血酶生成。
  • 机制可能为降低因子V与因子VIII竞争活化血小板表面的因子Xa。

研究设计与样本

  • 基于经血流介导凝血数学模型的全局敏感性分析,筛选候选修饰因子。
  • 用校准自动血栓成像和剪切率100每秒的胶原-组织因子表面流动实验验证。

主要发现

  • 模拟识别低正常水平因子V(50%)为最强修饰因子,联合高正常水平凝血酶原(150%)时凝血酶增强更明显。
  • 低正常水平因子V或部分抑制因子V(60%活性)在因子VIII抑制或缺乏血浆中增强凝血酶生成。
  • 部分抑制因子V(60%)增加轻度和中度因子VIII缺乏个体全血流动实验中的纤维蛋白沉积,高正常水平凝血酶原可放大此效应。

关键数值与推荐

  • 低正常水平因子V定义为50%。
  • 高正常水平凝血酶原定义为150%。
  • 部分抑制因子V定义为60%活性。
  • 流动实验剪切率为100每秒。

临床怎么用

  • 因子V水平可能解释血友病A出血表型异质性,但尚需临床验证。
  • 部分抑制因子V或调节凝血酶原水平是潜在研究方向的干预靶点。

局限性

  • 主要基于数学模型和体外实验,未在临床人群中验证。
  • 原文未报告样本量、P值等具体统计信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The variability in bleeding patterns among individuals with hemophilia A, who have similar factor VIII (FVIII) levels, is significant and the origins are unknown. OBJECTIVE: To use a previously validated mathematical model of flow-mediated coagulation as a screening tool to identify parameters that are most likely to enhance thrombin generation in the context of FVIII deficiency. METHODS: We performed a global sensitivity analysis (GSA) on our mathematical model to identify potential modifiers of thrombin generation. Candidates from the GSA were confirmed by calibrated automated thrombography (CAT) and flow assays on collagen-tissue factor (TF) surfaces at a shear rate of 100 per second. RESULTS: Simulations identified low-normal factor V (FV) (50%) as the strongest modifier, with additional thrombin enhancement when combined with high-normal prothrombin (150%). Low-normal FV levels or partial FV inhibition (60% activity) augmented thrombin generation in FVIII-inhibited or FVIII-deficient plasma in CAT. Partial FV inhibition (60%) boosted fibrin deposition in flow assays performed with whole blood from individuals with mild and moderate FVIII deficiencies. These effects were amplified by high-normal prothrombin levels in both experimental models. CONCLUSIONS: These results show that low-normal FV levels can enhance thrombin generation in hemophilia A. Further explorations with the mathematical model suggest a potential mechanism: lowering FV reduces competition between FV and FVIII for factor Xa (FXa) on activated platelet surfaces (APS), which enhances FVIII activation and rescues thrombin generation in FVIII-deficient blood.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Link KG, Stobb MT, Sorrells MG, et al. A mathematical model of coagulation under flow identifies factor V as a modifier of thrombin generation in hemophilia A. J Thromb Haemost. 2019. PMID: 31562694. doi:10.1111/jth.14653

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。